Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Bibliographic Details
Main Authors:	D Shyangdan, C Clar, N Ghouri, R Henderson, T Gurung, D Preiss, N Sattar, A Fraser, N Waugh
Format:	Article
Language:	English
Published:	NIHR Journals Library 2011-11-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta15380

Similar Items

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
by: N Waugh, et al.
Published: (2013-11-01)

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
by: Hannele Yki-Järvinen
Published: (2015-11-01)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010-11-01)

NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
by: L.V. Chistova, et al.
Published: (2010-11-01)

Pediatric non-alcoholic fatty liver disease
by: Delvin Edgard, et al.
Published: (2015-01-01)

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.
by: Christine Clar, et al.
Published: (2009-07-01)

Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)

Anti-obesity and insulin-sensitising effects of a glycosaminoglycan mix
by: Bàrbara Reynés, et al.
Published: (2016-10-01)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
by: Serena Scapaticci, et al.
Published: (2021-04-01)

The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.
by: Emma L Anderson, et al.
Published: (2015-01-01)

Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis
by: Sharma Pawana, et al.
Published: (2010-12-01)

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
by: Jiayin Yao, et al.
Published: (2013-01-01)

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
by: Jiayin Yao, et al.
Published: (2013-03-01)

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
by: Gurung T, et al.
Published: (2015-08-01)

Assessment of Insulin Resistance in Ultrasonographically Diagnosed Cases of Non-Alcoholic Fatty Liver Disease
by: Debabrata Maitra, et al.
Published: (2019-08-01)

Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease
by: Rocio Aller, et al.
Published: (2011-01-01)

Effects of insulin sensitising agents on pancreatic beta cell function
by: Duffy, Joan
Published: (2004)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
by: Fan Du, et al.
Published: (2021-02-01)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
by: Mehdi Foroughi, et al.
Published: (2016-01-01)

Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans
by: Irene Esposito, et al.
Published: (2020-12-01)

Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study
by: Weiwei Zhang, et al.
Published: (2017-05-01)

Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease
by: Chris E. Shannon, et al.
Published: (2021-03-01)

Hypolipidemic therapy in patients with non-alcoholic fatty liver disease
by: L. B Lazebnik, et al.
Published: (2010-03-01)

Transient elastography in non-alcoholic fatty liver disease
by: Ludovico Abenavoli, M.D. Ph.D., et al.
Published: (2012-03-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Commentary. Hypoxia and non alcoholic fatty liver disease
by: Byrne, C.D
Published: (2010)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
by: Bilon Khambu, et al.
Published: (2018-09-01)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
by: Francesca Cainelli, et al.
Published: (2020-02-01)

Non-Alcoholic Fatty Liver Disease
by: Bayard, Max, et al.
Published: (2007)

Non-Alcoholic Fatty Liver Disease
by: Hui-Hui Tan MRCP(UK), FAMS, et al.
Published: (2010-03-01)

Non alcoholic fatty liver disease
by: Nahum Méndez-Sánchez
Published: (2009-01-01)

Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
by: Himanshu Rana, et al.
Published: (2016-08-01)

Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease
by: Qing Liu, et al.
Published: (2011-04-01)

The Effects of Resistance Training on Body and Liver Fat Stores and Insulin Resistance in Peoples with Non-Alcoholic Fatty Liver Disease
by: Mohammad Ebrahim GHAMAR CHEHREH, et al.
Published: (2020-03-01)

Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease
by: Kátia Cansanção, et al.
Published: (2018-10-01)

Metabolic disturbances in non-alcoholic fatty liver disease
by: Byrne, Christopher D., et al.
Published: (2009)

Current treatment of non-alcoholic fatty liver disease
by: Ahmed, Mohamed H., et al.
Published: (2008)

The Extracts of Mulberry Leaves inhibits Non-Alcoholic Fatty Liver Disease and Alcoholic Fatty Liver Disease
by: Hui-Ting Lin, et al.
Published: (2014)

State of endogenous intoxication and immune-inflammatory response in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease
by: N.R. Matkovska, et al.
Published: (2019-04-01)

New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication
by: Jennifer H. Gunter, et al.
Published: (2013-01-01)